Caricamento...

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib

Background: Differentiated thyroid cancers (DTC) make up 95% of all thyroid cancers. Radioactive iodine therapy (RAI Rx) is an integral part of DTC management. However, 5-15% of DTC and 50% of metastatic DTC become resistant to RAI Rx and carries a 10-year survival of only 10%. One of the newer ther...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Zayouna, Christine, Sonnabend, Hajerah, Amblee, Ambika
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090069/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1833
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !